Review
Published on 11 Sep 2018
Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2018.00370
- 20,499 views
- 117 citations
Review
Published on 11 Sep 2018
in Molecular and Cellular Oncology
Mini Review
Published on 20 Oct 2014
in Immunological Tolerance and Regulation
Review
Published on 16 Sep 2025
in Pharmacology of Anti-Cancer Drugs